Marketing to the “Dead Internet”: Why Legacy AdTech Misses Real People
The “Dead Internet Theory” has gained quite a bit of traction since it was brought to light in 2021. According to The University of New South Wales the dead internet…
Using AI to Create Synergy Between HCP and DTC Marketing Strategies
Pharmaceutical marketing has long treated healthcare providers (HCPs) and patients as separate audiences. Distinct in their needs, their influence, and their channels of communication. But as the healthcare journey grows…
Privacy as an Innovation Driver: Removing the Reliance on Individual Health Data in Healthcare Marketing
As the regulatory landscape tightens around data privacy, many healthcare advertisers are forced to react, limiting functionality, scaling back targeting, or navigating consent challenges. BranchLab took a different path. From…
Pharma marketers weigh economy and chance of TV ad ban during upfronts season
As economic and regulatory uncertainty loom over the 2025 TV upfronts, pharma marketers are rethinking how they show up across media. In Sam Bradley’s latest piece for Digiday, our EVP…
Why Banning Health Data Tracking Benefits Everyone, Even Advertisers
by Josh Walsh, Co-Founder & CEO, BranchLab A recent Harvard Law publication warns that Washington’s My Health My Data Act (WMHMD) could disrupt widely used advertising techniques. It’s right. And…
Protecting Patients and Performance
As regulations tighten, cleanroom technology offers a sustainable, compliant path forward for health advertising. The advertising technology ecosystem is at a crossroads. Eighty percent of consumers are concerned and confused…
After FTC Commissioners Fired, Marketers Speculate on Future of Industry Regulation
BranchLab CEO, Josh Walsh, weighs in on the role state regulations will play for marketers, especially pharma advertisers, in the vacuum of federal regulation.
How New York’s Recent Health Data Privacy Law Impacts Pharma Advertising
The advertising landscape is changing, especially for healthcare and pharmaceutical companies. This January, the New York Senate approved S929 – a groundbreaking data privacy law and significant step towards greater…
20 Ad Tech Executives Predict 2025 Trends
BranchLab’s Michael Parkes predicts: “State privacy regulations, such as Washington’s My Health My Data Act, will profoundly reshape pharmaceutical advertising by imposing strict limitations on the use of health data….
Could Washington State Transform Pharmaceutical Advertising Forever?
Unpacking the Pivotal Harvard Law Paper. Pharmaceutical advertising is undergoing a seismic shift, and Washington State is at the epicenter. A recent paper from Harvard Law has issued a transformative…
Is Targeted Pharma Advertising Over? Not Quite
BranchLab’s Michael Parkes provides an overview of the emerging state regulations impacting the media strategies of pharmaceutical and healthcare brands, offering recommendations on how to navigate a new era of…
Health and Wellness Brands Brace for Ad Restrictions on Meta
BranchLab CEO, Josh Walsh, weighs in on Meta’s move to implement stricter policies for health and wellness brands.